Clinical Trial Update: A Study to Evaluate the Effectiveness and Safety of Extended-Release (ER) Paliperidone Compared With Placebo in Delaying the Recurrence of Symptoms in Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the effectiveness and safety of extended-release paliperidone vs placebo to delay recurrence of symptoms in Bipolar I disorder; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Paliperidone ER (paliperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED | Results posted: 2012-03-05